Ironwood Pharmaceuticals, Inc.
Modified or Targeted Release Formulations of Linaclotide

Abstract:

The present invention relates to delayed release pharmaceutical compositions comprising linaclotide or pharmaceutically acceptable salts thereof, as well as to various methods and processes for the preparation and use of the compositions.